Attributes | Values |
---|
rdf:type
| |
description
| - wetenschappelijk artikel (nl)
- article scientifique publié en 2005 (fr)
- наукова стаття, опублікована в листопаді 2005 (uk)
- im November 2005 veröffentlichter wissenschaftlicher Artikel (de)
- scientific article published on 15 November 2005 (en)
- գիտական հոդված հրատարակված 2005 թվականի նոյեմբերի 15-ին (hy)
- artículu científicu espublizáu en payares de 2005 (ast)
|
publication date
| |
publication date
| |
author name string
| |
author name string
| - Anne Cooper
- Andrew Baxter
- Kerry Moakes
- Alan Wallace
- Elizabeth Kinchin
|
rdfs:label
| - Hit-to-Lead studies: the discovery of potent, orally bioavailable thiazolopyrimidine CXCR2 receptor antagonists (en)
- Hit-to-Lead studies: the discovery of potent, orally bioavailable thiazolopyrimidine CXCR2 receptor antagonists (nl)
|
skos:prefLabel
| - Hit-to-Lead studies: the discovery of potent, orally bioavailable thiazolopyrimidine CXCR2 receptor antagonists (en)
- Hit-to-Lead studies: the discovery of potent, orally bioavailable thiazolopyrimidine CXCR2 receptor antagonists (nl)
|
name
| - Hit-to-Lead studies: the discovery of potent, orally bioavailable thiazolopyrimidine CXCR2 receptor antagonists (en)
- Hit-to-Lead studies: the discovery of potent, orally bioavailable thiazolopyrimidine CXCR2 receptor antagonists (nl)
|
author
| |
author
| |
title
| |
title
| - Hit-to-Lead studies: the discovery of potent, orally bioavailable thiazolopyrimidine CXCR2 receptor antagonists (en)
|
page(s)
| |
page(s)
| |
instance of
| |
instance of
| |
PubMed ID
| |
PubMed ID
| |
PubMed ID
| |
published in
| |
published in
| |
issue
| |
volume
| |
issue
| |
volume
| |
DOI
| |
DOI
| |
DOI
| - 10.1016/J.BMCL.2005.10.091
|
is about
of | |
is cites work
of | |
is cites work
of | |